Literature DB >> 17213652

Human MDR1 and MRP1 recognize berberine as their transport substrate.

Nobukazu Shitan1, Miyako Tanaka, Koichiro Terai, Kazumitsu Ueda, Kazufumi Yazaki.   

Abstract

To examine whether human ATP-binding cassette (ABC) transporters play a role in the detoxification of plant alkaloid berberine, we investigated berberine transport using multidrug resistance protein1 (MDR1) and multidrug resistance-associated protein1 (MRP1). Cells expressing MDR1 or MRP1 accumulated less berberine. Berberine accumulation depended on the cellular ATP level, and was reversed by typical inhibitors of MDR1, suggesting that human MDR1 and MRP1 directly efflux berberine as their substrate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213652     DOI: 10.1271/bbb.60441

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).

Authors:  Anne T Nies; Elke Herrmann; Manuela Brom; Dietrich Keppler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

2.  Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.

Authors:  Sutapa Mahata; Alok C Bharti; Shirish Shukla; Abhishek Tyagi; Syed A Husain; Bhudev C Das
Journal:  Mol Cancer       Date:  2011-04-15       Impact factor: 27.401

3.  Tissue distribution of berberine and its metabolites after oral administration in rats.

Authors:  Xiang-Shan Tan; Jing-Yi Ma; Ru Feng; Chao Ma; Wen-Jing Chen; Yu-Peng Sun; Jie Fu; Min Huang; Chi-Yu He; Jia-Wen Shou; Wen-Yi He; Yan Wang; Jian-Dong Jiang
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

Review 4.  Naturally Occurring PCSK9 Inhibitors.

Authors:  Maria Pia Adorni; Francesca Zimetti; Maria Giovanna Lupo; Massimiliano Ruscica; Nicola Ferri
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

5.  A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells.

Authors:  Vivian Osei Poku; Surtaj Hussain Iram
Journal:  PeerJ       Date:  2022-01-05       Impact factor: 2.984

6.  Effects of berberine and hwangryunhaedok-tang on oral bioavailability and pharmacokinetics of ciprofloxacin in rats.

Authors:  Youn-Hwan Hwang; Won-Kyung Cho; Doorye Jang; Jeong-Ho Ha; Kiyoun Jung; Hyo-In Yun; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-24       Impact factor: 2.629

7.  Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages.

Authors:  Weibin Zha; Guangji Wang; Weiren Xu; Xuyuan Liu; Yun Wang; Beth S Zha; Jian Shi; Qijin Zhao; Phillip M Gerk; Elaine Studer; Phillip B Hylemon; William M Pandak; Huiping Zhou
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

8.  Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.

Authors:  Roger Shen; Jane J Kim; Mingyi Yao; Tamer A Elbayoumi
Journal:  Int J Nanomedicine       Date:  2016-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.